CUYRF(CUYRF)
CUYRF
No analyst ratings available
No analyst price targets available for CUYRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $102.90B | $112.10B | $127.72B | $148.38B | $165.93B |
| Low | $100.98B | $107.21B | $123.68B | $143.68B | $160.67B |
| High | $106.55B | $116.69B | $132.62B | $154.07B | $172.29B |
| EBITDA Avg | $33.19B | $36.16B | $41.20B | $47.86B | $53.52B |
| Low | $32.57B | $34.58B | $39.89B | $46.35B | $51.83B |
| High | $34.37B | $37.64B | $42.78B | $49.70B | $55.57B |
| EBIT Avg | $30.34B | $33.05B | $37.66B | $43.75B | $48.93B |
| Low | $29.77B | $31.61B | $36.47B | $42.37B | $47.38B |
| High | $31.42B | $34.41B | $39.11B | $45.43B | $50.80B |
| Net Income Avg | $17.02B | $19.83B | $22.94B | — | — |
| Low | $16.32B | $19.01B | $22.00B | — | — |
| High | $17.87B | $20.82B | $24.09B | — | — |
| EPS Avg | $1055.06 | $1229.13 | $1422.27 | — | — |
| Low | $1011.60 | $1178.50 | $1363.69 | — | — |
| High | $1107.67 | $1290.42 | $1493.19 | — | — |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 2 / — | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $25.53B | $26.42B | $27.29B |
| Low | $24.81B | $25.88B | $26.63B |
| High | $26.38B | $27.40B | $28.25B |
| EBITDA Avg | $8.23B | $8.52B | $8.80B |
| Low | $8.00B | $8.35B | $8.59B |
| High | $8.51B | $8.84B | $9.11B |
| EBIT Avg | $7.53B | $7.79B | $8.05B |
| Low | $7.32B | $7.63B | $7.85B |
| High | $7.78B | $8.08B | $8.33B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — | 1 / — |